Key facts
- This page summarizes Marie-Claude Jacques's Form 4 filing for Catheter Precision, Inc. (VTAK).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 May 2024, 17:02.
Marie-Claude Jacques - 01 May 2024 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- VTAK
- Reported as of
- 01 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 May 2024, 17:02:09 UTC
- Next SEC filing
- 31 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jacques Marie-Claude
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Marie-Claude Jacques filed Form 4 for Catheter Precision, Inc. (VTAK) on 03 May 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VTAK
transaction
Derivative
Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +250,000
- Change %
- Price
- $0.000000
- Shares after
- 250,000
- Date
- 01 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 250,000
- Exercise price
- $0.5321
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Options vests annually for five years.